Edition:
United Kingdom

Infant Bacterial Therapeutics AB (IBTb.ST)

IBTb.ST on Stockholm Stock Exchange

224.50SEK
24 May 2019
Change (% chg)

6.50kr (+2.98%)
Prev Close
218.00kr
Open
218.00kr
Day's High
225.50kr
Day's Low
218.00kr
Volume
9,354
Avg. Vol
14,250
52-wk High
225.50kr
52-wk Low
115.00kr

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.061
FY 2018 Dec '18 0.00 -2.151
Sep '18 0.00 -0.711
Jun '18 0.00 0.059
Mar '18 0.00 -0.965
FY 2017 Dec '17 0.00 -1.543
Sep '17 0.00 -0.833
Jun '17 0.12 -2.512
Mar '17 0.12 -1.578
 
*Note: Units in Millions ofSwedish Krona
**Note: Units in Swedish Krona

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.30 32.55
P/E High - Last 5 Yrs. -- 43.17 48.12
P/E Low - Last 5 Yrs. -- 22.71 23.41
Beta -- 0.86 0.87
Price to Sales (TTM) 1,874.91 6.59 8.43
Price to Book (MRQ) 9.35 5.12 5.27
Price to Tangible Book (MRQ) 10.93 5.84 6.74
Price to Cash Flow (TTM) -- 23.07 24.12
% Owned Institutions -- 0.87 1.65

Dividends

  Company industry sector
Dividend Yield -- 1.43 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.37
Dividend 5 Year Growth Rate -- 4.00 4.71
Payout Ratio(TTM) -- 42.19 39.59

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.43 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 6.61 8.04
Sales - 5 Yr. Growth Rate -- 10.48 10.84
EPS (MRQ) vs Qtr. 1 Yr. Ago 45.66 45.66 47.76
EPS (TTM) vs TTM 1 Yr. Ago -185.52 -- --
EPS - 5 Yr. Growth Rate -- 9.90 10.46
Capital Spending - 5 Yr. Growth Rate -- 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) 8.95 2.87 2.98
LT Debt to Equity (MRQ) 0.00 8.86 11.34
Total Debt to Equity (MRQ) 0.00 12.87 16.04
Interest Coverage (TTM) -- 32.47 28.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 59.50 52.11 52.39
Gross Margin - 5 Yr. Avg. -- 49.67 50.39
EBITD Margin (TTM) -11,130.50 -- --
EBITD - 5 Yr. Avg -- 17.26 12.41
Operating Margin (TTM) -11,130.50 13.53 5.67
Operating Margin - 5 Yr. Avg. -- 13.69 8.01
Pre-Tax Margin (TTM) -11,083.25 11.88 4.70
Pre-Tax Margin - 5 Yr. Avg. -- 14.09 8.29
Net Profit Margin (TTM) -11,083.25 8.79 1.43
Net Profit Margin - 5 Yr. Avg. -- 10.58 4.69
Effective Tax Rate (TTM) -- 22.13 22.13
Effective Tax Rate - 5 Yr. Avg. -- 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 928,433,188 819,677,428
Net Income/Employee (TTM) -- 105,143,011 92,782,969
Receivable Turnover (TTM) 0.75 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.42
Asset Turnover (TTM) 0.00 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.35 10.98 10.65
Return on Assets - 5 Yr. Avg. -- 12.41 11.78
Return on Investment (TTM) -42.09 14.23 13.82
Return on Investment - 5 Yr. Avg. -- 16.18 15.32
Return on Equity (TTM) -42.09 15.46 15.25
Return on Equity - 5 Yr. Avg. -- 17.07 16.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -68,585.32 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Infant Bacterial Therapeutics AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 60.45 -- 98 29
13 Week 43.43 -- 94 42
26 Week 137.66 -- 98 43
52 Week 150.22 -- 95 11
YTD 222.73 -- 98 39
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 42.01%
# of Holders: 21
Total Shares Held: 4,557,310
3 Mo. Net Change: 690,569
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 5
# Reduced Positions: 3
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.